genedrive plc (LSE: GDR), the near-patient molecular diagnostics company, announces unaudited interim results for the six months to 31 December 2020.
Genedrive PLC (GDR.L) Distribution agreement
Genedrive enters distribution agreement with Mountain Horse Solutions
Genedrive PLC (GDR.L) Antibiotic Induced Hearing Loss update
New clinical guidance in the UK supports assay